Abstract CT264: Clinical Phase II Study of SCO-101 - an Inhibitor of SRPK1 and ABCG2 - Restoring Sensitivity to FOLFIRI in Metastatic FOLFIRI Resistant Colorectal Cancer Patients
Cancer research（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined